Frontiers in Cardiovascular Medicine

MARCH 6, 2024

Background and aims In the non-metropolitan region of Brandenburg (Germany), which is characterized by high rates of cardiovascular diseases and underserved medical care, there is a lack of awareness regarding lipoprotein(a) [Lp(a)] as a risk factor. 3.95, p  = 0.003). 3.95, p  = 0.003). vs. 45.8%; 17.6% vs. 13.9%, p  = 0.001).

Risk Factors 59

Risk Factors Cardiovascular Disease Peripheral Arterial Disease Cerebrovascular Disease 59

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Methods This narrative review examines the contemporary literature assessing intermediate- and long-term event rates in patients with established CV disease treated with statins. Recurrent stroke occurs in up to 19% of patients seven years after a first cerebrovascular event.

Peripheral Arterial Disease 64

Peripheral Arterial Disease Cardiovascular Disease Cerebrovascular Disease Coronary Artery Disease 64

Frontiers in Cardiovascular Medicine

JANUARY 21, 2024

Background and aims Epidemiology of atherosclerotic cardiovascular disease might be different in patients with polygenic hypercholesterolemia plus high levels (≥30 mg/dl) of Lp(a) (H-Lpa) than in those with polygenic hypercholesterolemia alone (H-LDL).

Cardiovascular Disease 45

Cardiovascular Disease Peripheral Arterial Disease Cerebrovascular Disease Coronary Artery Disease 45

DAIC

JULY 29, 2024

mtaschetta-millane Mon, 07/29/2024 - 09:16 July 29, 2024 — CorVascular , a leading producer of peripheral arterial disease (PAD) / peripheral vascular disease (PVD) testing devices, today announced the U.S. Food and Drug Administration (FDA) has cleared its VasoGuard V-Series as Class II medical devices.

Peripheral Arterial Disease 108

Peripheral Arterial Disease Certification Cerebrovascular Disease Quality of Life 108

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 26 Similarly, over one-third of ASCVD patients have hsCRP levels above 2 mg/L which indicates a higher risk of heart disease.12,27 4 In the U.S.

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111